Changes in the brain expression of alpha-2 subunits of the GABA-A receptor after chronic restraint stress in low- and high-anxiety rats

Behavioural Brain Research

Volumn 253, Issue , 2013, Pages 337-345

  Wisłowska Stanek, Aleksandra ^a   Lehner, Małgorzata ^b   Skórzewska, Anna ^b   Krzaścik, Paweł ^a   Maciejak, Piotr ^a,b   Szyndler, Janusz ^a   Ziemba, Andrzej ^c   Płaźnik, Adam ^a,b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^c MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Alpha 2 GABA A receptors; Chronic restraint stress; Elevated plus maze; Individual differences; Open field test; Porsolt test

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR ALPHA2; CORTICOSTERONE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BASOLATERAL AMYGDALA; BRAIN LEVEL; CHRONIC STRESS; CONTEXTUAL FEAR TEST; CONTROLLED STUDY; DENTATE GYRUS; DEPRESSION; ELEVATED PLUS MAZE TEST; EXPERIMENTAL TEST; FEAR; GABAERGIC TRANSMISSION; HIPPOCAMPUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MOTOR CORTEX; NONHUMAN; OPEN FIELD TEST; PORSOLT TEST; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STRAIN DIFFERENCE;

ALPHA-2 GABA-A RECEPTORS; CHRONIC RESTRAINT STRESS; ELEVATED PLUS MAZE; INDIVIDUAL DIFFERENCES; OPEN FIELD TEST; PORSOLT TEST;

AMYGDALA; ANIMALS; ANXIETY; BODY WEIGHT; BRAIN CHEMISTRY; CHRONIC DISEASE; CORTICOSTERONE; DENTATE GYRUS; FEAR; IMMUNOHISTOCHEMISTRY; INDIVIDUALITY; MALE; MOTOR ACTIVITY; MOTOR CORTEX; RATS; RATS, WISTAR; RECEPTORS, GABA-A; RESTRAINT, PHYSICAL; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 84882753415     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.07.042     Document Type: Article

References (67)

1. Buynitsky T., Mostofsky D.I. Restraint stress is in biobehavioral research: recent developments. Neurosci Biobehav Rev 2009, 33:1089-1098.
2. Chiba S., Numakawa T., Ninomiya M., Richards M.C., Wakabayashi Kunugi H. Chronic restraint stress causes anxiety- and depression-like behaviors, downregulates glucocorticoid receptor expression, and attenuates glutamate release induced by brain-derived neurotrophic factor in prefrontal cortex. Prog Neuro-Psychopharmacol Biol Psychiatry 2012, 39:112-119.
3. Eiland L., Ramroop J., Hill M.N., Manley J., McEwen B.S. Chronic juvenile stress produces corticolimbic dendritic architectural remodeling and modulates emotional behavior in male and female rats. Psychoneuroendocrinology 2012, 37:39-47.
4. Zamora-Gonzales E.O., Santerre A., Palomera-Avalos V., Morales-Villagran A. A chronic combinatory stress model that activates the HPA axis and avoids habituation in BALB/C mice. J Neurosci Methods 2013, 213:70-75.
5. Drevets W.C., Price J.L., Simpson J.R., Todd R.D., Reich T., Vannier M., et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997, 386:824-827.
6. Mika A., Mazur G.J., Hoffman A.N., Talboom J.S., Bimonte-Nelson H.A., Sanabria F., et al. Chronic stress impairs prefrontal cortex-dependent response inhibition and spatial working memory. Behav Neurosci 2012, 126:605-619.
7. Mitra R., Jadhav S., McEwen B.S., Vyas A., Chattarji S. Stress duration modulates the spatiotemporal patterns of spine formation in the basolateral amygdala. Proc Natl Acad Sci USA 2005, 102:9371-9376.
8. Palazidou E. The neurobiology of depression. Br Med Bull 2012, 101:127-145.
9. Vyas A., Mitra R., Shankaranarayana Rao B.S., Chattarji S. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J Neurosci 2002, 22:6810-6818.
10. Jaggi A.S., Bhatia N., Kumar N., Singh N., Anand P., Dhawan R. A review on animal models for screening potential anti-stress agents. Neurol Sci 2011, 32:993-1005.
11. O'Mahony C.M., Clarke G., Gibney S., Dinan T.G., Cryan J.F. Strain differences in the neurochemical response to chronic restraint stress in the rat: relevance to depression. Pharmacol Biochem Behav 2011, 97:690-699.
12. Hodes G.E. Sex, stress, and epigenetics: regulation of behavior in animal models of mood disorders. Biol Sex Differ 2013, 4:1.
13. Liu X., Wu R., Tai F., Ma L., Wei B., Yang X., et al. Effect of housing on stress induced emotional and neuroendocrine alteration. Brain Res 2013, 1502:71-80.
14. Zhang W., Rosenkranz J.A. Repeated restraint stress enhances cue-elicited conditioned freezing and impairs acquisition of extinction in an age-dependent manner. Behav Brain Res 2013, 248:12-24.
15. Dallman M.F. Modulation of stress responses: how we cope with excess glucocorticoids. Exp Neurol 2007, 206:179-182.
16. Möhler H. The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology 2012, 62:42-53.
17. Engin E., Liu J., Rudolph U. α2-containing GABA(A) receptors: a target for the development of novel treatment strategies for CNS disorders. Pharmacol Therap 2012, 136:142-152.
18. Hines R.M., Davies P.A., Moss S.J., Maguire J. Functional regulation of GABAA receptors in nervous system pathologies. Curr Opin Neurobiol 2012, 22:552-558.
19. Sanacora G., Mason G.F., Krystal J.H. Impairment of GABAergic neurotransmission in depression: new insights from new imaging studies. Crit Rev Neurobiol 2000, 14:23-45.
20. Lehner M., Taracha E., Skórzewska A., Turzyńska D., Sobolewska A., Maciejak P., et al. Expression of c-Fos and CRF in the brains of rats differing in the strength of a fear response. Behav Brain Res 2008, 188:154-167.
21. Lehner M., Wisłowska-Stanek A., Taracha E., Maciejak P., Szyndler J., Skórzewska A., et al. The expression of c-Fos and colocalisation of c-Fos and glucocorticoid receptors in brain structures of low and high anxiety rats subjected to extinction trials and re-learning of a conditioned fear response. Neurobiol Learn Memory 2009, 92:535-543.
22. Lehner M., Wisłowska-Stanek A., Skórzewska A., Maciejak P., Szyndler J., Turzyńska D., et al. Differences in the density of GABA-A receptor alpha-2 subunits and gephyrin in brain structures of rats selected for low and high anxiety in basal and fear-stimulated conditions, in a model of contextual fear conditioning. Neurobiol Learn Memory 2010, 94:499-508.
23. Lehner M., Wislowska-Stanek A., Skorzewska A., Maciejak P., Szyndler J., Turzynska D., et al. Expression of N-methyl-d-aspartate (R)(GluN2B) - subunits in the brain structures of rats selected for low and high anxiety. J Physiol Pharmacol 2011, 62:473-482.
24. Wisłowska-Stanek A., Lehner M., Skórzewska A., Maciejak P., Szyndler J., Turzyńska D., et al. Corticosterone attenuates conditioned fear responses and potentiates the expression of GABA-A receptor alpha-2 subunits in the brain structures of rats selected for high anxiety. Behav Brain Res 2012, 235:30-35.
25. Wisłowska-Stanek A., Lehner M., Skórzewska A., Maciejak P., Szyndler J., Turzyńska D., et al. Effects of d-cycloserine and midazolam on the expression of the GABA-A alpha-2 receptor subunits in brain structures of fear conditioned rats. Behav Brain Res 2011, 225:655-659.
26. Skórzewska A., Bidziński A., Lehner M., Turzyńska D., Wisłowska-Stanek A., Sobolewska A., et al. The effects of acute and chronic administration of corticosterone on rat behavior in two models of fear responses, plasma corticosterone concentration, and c-Fos expression in the brain structures. Pharmacol Biochem Behav 2006, 85:522-534.
27. Taracha E., Hamed A., Krza̧ścik P., Lehner M., Skórzewska A., Płaźnik A., et al. Inter-individual diversity and intra-individual stability of amphetamine-induced sensitization of frequency-modulated 50-kHz vocalization in Sprague-Dawley rats. Psychopharmacology 2012, 222:619-632.
28. Porsolt R.D., Anton G., Blavet N., Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 1978, 47:379-391.
29. Płaźnik A., Danysz W., Kostowski W. A stimulatory effect of intraaccumbens injections of noradrenaline on the behavior of rats in the forced swim test. Psychopharmacology (Berl) 1985, 87(1):119-123.
30. Kostowski W., Danysz W., Dyr W., Jankowska E., Krza̧ścik P., Pałejko W., et al. MIF-1 potentiates the action of tricyclic antidepressants in an animal model of depression. Peptides 1991, 12:915-918.
31. Rada P., Moreno S.A., Tucci S., Gonzalez L.E., Harrison T., Chau D.T., et al. Glutamate release in the nucleus accumbens is involved in behavioral depression during the PORSOLT swim test. Neuroscience 2003, 119:557-565.
32. Flagstad P., Glenthøj B.Y., Didriksen M. Cognitive deficits caused by late gestational disruption of neurogenesis in rats: a preclinical model of schizophrenia. Neuropsychopharmacology 2005, 30:250-260.
33. Paxinos G., Watson C.H. The rat brain in stereotaxic coordinates 1998, Academic Press Inc., San Diego CA.
34. Krystal J.H., Sanacora G., Blumberg H., Anand A., Charney D.S., Marek G., et al. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry 2002, 7:S71-S80.
35. Klumpers U.M., Veltman D.J., Drent M.L., Boellaard R., Comans E.F., Meynen G., et al. Reduced parahippocampal and lateral temporal GABAA [11C]flumazenil binding in major depression: preliminary results. Eur J Nucl Med Mol Imag 2010, 37:565-574.
36. Kalueff A.V., Nutt D.J. Role of GABA in anxiety and depression. Depress Anxiety 2007, 24:495-517.
37. Luscher B., Shen Q., Sahir N. The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry 2011, 16:383-406.
38. Karolewicz B., Maciag D., O'Dwyer G., Stockmeier C.A., Feyissa A.M., Rajkowska G. Reduced level of glutamic amid decarboxylase-67kDa in the prefrontal cortex in major depression. Int J Neuropsychopharmacol 2010, 13:411-420.
39. Sanacora G., Mason G.F., Rothman D.L., Krystal J.H. Increased occipital cortex GABA concentration in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry 2002, 159:663-665.
40. Sanacora G., Mason G.F., Rothman D.L., Hyder F., Ciarcia J.J., Ostroff R.B., et al. Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry 2003, 160:577-579.
41. Sanacora G., Gueorguieva R., Epperson C.N., Wu Y.T., Appel M., Rothman D.L., et al. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry 2004, 61:705-713.
42. Vollenweider I., Smith K.S., Keist R., Rudolph U. Antidepressant-like properties of alpha-2 containing GABA(A) receptor. Behav Brain Res 2011, 217:77-80.
43. Lussier A.L., Romay-Tallón R., Caruncho H.J., Kalynchuk L.E. Altered GABAergic and glutamatergic activity within the rat hippocampus and amygdala in rats subjected to repeated corticosterone administration but not restraint stress. Neuroscience 2013, 231:38-48.
44. Fava M., Schaefer K., Huang H., Wilson A., Iosifescu D.V., Mischoulon D., et al. A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression. J Clin Psychiatry 2011, 72:473-479.
45. Roxo M.R., Franceschini P.R., Zubaran C., Kleber F.D., Sander J.W. The limbic system conception and its historical evolution. Sci World J 2011, 11:2428-2440.
46. LeDoux J. Emotional networks and motor control: a fearful view. Prog Brain Res 1996, 107:437-446.
47. Uylings H.B., Groenewegen H.J., Kolb B. Do rats have a prefrontal cortex?. Behav Brain Res 2003, 146:3-17.
48. Hoover W.B., Vertes R.P. Anatomical analysis of afferent projections to the medial prefrontal cortex in the rat. Brain Struct Funct 2007, 212:149-179.
49. Grønli J., Bramham C., Murison R., Kanhema T., Fiske E., Bjorvatn B., et al. Chronic mild stress inhibits BDNF protein expression and CREB activation in the dentate gyrus but not in the hippocampus proper. Pharmacol Biochem Behav 2006, 85:842-849.
50. Li Y., Ji Y.J., Jiang H., Liu D.X., Zhang Q., Fan S.J., et al. Effects of unpredictable chronic stress on behavior and brain-derived neurotrophic factor expression in CA3 subfield and dentate gyrus of the hippocampus in different aged rats. Chin Med J (Engl) 2009, 122:1564-1569.
51. Cieślik K., Sowa-Kućma M., Ossowska G., Legutko B., Wolak M., Opoka W., et al. Chronic unpredictable stress-induced reduction in the hippocampal brain-derived neurotrophic factor (BDNF) gene expression is antagonized by zinc treatment. Pharmacol Rep 2011, 63:537-543.
52. Porcher C., Hatchett C., Longbottom R.E., McAinch K., Shira T.S., Moss S.J., et al. Positive feedback regulation between gamma-aminobutyric acid type A receptor signaling and brain-derived neurotrophic factor (BDNF) release in developing neurons. J Biol Chem 2011, 286:21667-21677.
53. Jagasia R., Steib K., Englberger E., Herold S., Faus-Kessler T., Saxe M., et al. GABA-cAMP response element-binding protein signaling regulates maturation and survival of newly generated neurons in the adult hippocampus. J Neurosci 2009, 29:7966-7977.
54. Duveau V., Laustela S., Barth L., Gianolini F., Vogt K.E., Keist R., et al. Spatiotemporal specificity of GABAA receptor-mediated regulation of adult hippocampal neurogenesis. Eur J Neurosci 2011, 34:362-373.
55. Cardinal R.N., Parkinson J.A., Hall J., Everitt B.J. Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci Biobehav Rev 2002, 26:321-352.
56. LeDoux J.E. Emotion circuits in the brain. Ann Rev Neurosci 2000, 23:155-184.
57. Zhang W., Rosenkranz J.A. Repeated restraint stress increases basolateral amygdala neuronal activity in an age-dependent manner. Neuroscience 2012, 226:459-474.
58. Likhtik E., Popa D., Apergis-Schoute J., Fidacaro G.A., Paré D. Amygdala intercalated neurons are required for expression of fear extinction. Nature 2008, 454:642-645.
59. Herry C., Ciocchi S., Senn V., Demmou L., Müller C., Lüthi A. Switching on and off fear by distinct neuronal circuits. Nature 2008, 454:600-606.
60. Fujimura J., Nagano M., Suzuki H. Differential expression of GABA(A) receptor subunits in the distinct nuclei of the rat amygdala. Brain Res Mol Brain Res 2005 Jul 29, 138(1):17-23.
61. McEwen B.S., Weiss J.M., Schwartz L.S. Uptake of corticosterone by rat brain and its concentration by certain limbic structures. Brain Res 1969, 16:227-241.
62. McEwen B.S., Stephenson B.S., Krey L.C. Radioimmunoassay of brain tissue and cell nuclear corticosterone. J Neurosci Methods 1980, 3:57-65.
63. Mikkelsen J.D., Bundzikova J., Larsen M.H., Hansen H.H., Kiss A. GABA regulates the rat hypothalamic-pituitary-adrenocortical axis via different GABA-A receptor alpha-subtypes. Ann New York Acad Sci 2008, 1148:384-392.
64. Feldman S., Weidenfeld J. The dorsal hippocampus modifies the negative feedback.effect of glucocorticoids on the adrenocortical and median eminence CRF-41 responses to photic stimulation. Brain Res 1993, 614(June (1-2)):227-232.
65. Herman J.P., Figueiredo H., Mueller N.K., Ulrich-Lai Y., Ostrander M.M., Choi D.C., et al. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol 2003, 24:151-180.
66. Cook C.J. Stress induces CRF release in the paraventricular nucleus, and both CRF and GABA release in the amygdala. Physiol Behav 2004, 82:751-762.
67. Levy B.H., Tasker J.G. Synaptic regulation of the hypothalamic-pituitary-adrenal axis and its modulation by glucocorticoids and stress. Front Cell Neurosci 2012, 6:24.